Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
InhaleRx Limited ( (AU:IRX) ) just unveiled an announcement.
InhaleRx Limited announced the cessation of 250,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of February 28, 2025. This development may impact the company’s capital structure and could influence investor perceptions, potentially affecting its market positioning and stakeholder interests.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based therapeutic products. The company is known for its innovative approach to drug delivery systems, targeting various medical conditions through inhalation technology.
YTD Price Performance: -34.29%
Average Trading Volume: 104,740
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$4.91M
Find detailed analytics on IRX stock on TipRanks’ Stock Analysis page.